What kicked off with a test batch initiated by Roche in 2018, quickly evolved into one the largest digital health innovation programs worldwide. 5 years and 16 batches later, our corporate partners and more than one hundred of the world’s best startups have explored digital health solutions with the goal to challenge clinical practices, improve data analytics, and enhance the patient journey across the continuum of care.
While more locations, new ecosystem partners and further focus areas have been added, one thing has remained unchanged: the focus on co-creation between corporates and startups to transform healthcare together.
What kicked off with a test batch initiated by Roche in 2018, quickly evolved into one the largest digital health innovation programs worldwide. 5 years and 16 batches later, our corporate partners and more than one hundred of the world’s best startups have explored digital health solutions with the goal to challenge clinical practices, improve data analytics, and enhance the patient journey across the continuum of care.
While more locations, new ecosystem partners and further focus areas have been added, one thing has remained unchanged: the focus on co-creation between corporates and startups to transform healthcare together.
From Munich into the Silicon Valley and further into the world: After running a successful trial batch and establishing a program with two batches per year in Munich, we explored our approach in the Silicon Valley, and in Singapore, resulting in an integrated program across three locations. And the success story will not stop there: We are currently exploring new locations in more key markets around the world. Stay tuned!
From facilitating the launch of a new company to accompanying a startup going global and co-commercializing new digital health solutions as a result of an ongoing collaboration between corporates and startups after a successful pilot project: Listen to our video testimonials to learn all about why it can be so rewarding to participate in the Startup Creasphere program!
From corporate partners to startups and ecosystem partners: perspectives on the achievements and benefits of the program
Chen Sagiv, co-founder of DeePathology, on how their participation in the trial batch of Startup Creasphere led to establishing DeePathology as a company
Hans Maria Heyn, founder of Smart4Diagnostics, on how Startup Creasphere helped them to get into the digital health market and to build a longterm relationship with Roche
When the cobas pulse system was introduced in the market, three startups from the Startup Creasphere program were part of the set of mobile apps included in the smart handheld for clinical professional
From 0 to 100+: Kicking it off with five startups in Munich, we could never have imagined that five years later, we would be looking back at 15 batches across three locations around the globe, running pilot projects with 107 startups from 14 countries to explore more than 18 focus areas – from advanced data analytics to digital biomarkers and disease management – to transform healthcare together. What a blast!
From 0 to 100+: Kicking it off with five startups in Munich, we could never have imagined that five years later, we would be looking back at 15 batches across three locations around the globe, running pilot projects with 107 startups from 14 countries to explore more than 18 focus areas – from advanced data analytics to digital biomarkers and disease management – to transform healthcare together. What a blast!
In this edition of the Startup Creasphere, the Roche innovation platform in Spain focused on ophthalmology and hepatocellular carcinoma, with a total of 56 participating startups from Spain and various European countries.
From June 4 to June 6, Munich was the place to be for startups, corporates, VCs, insurers, and further players interested in transforming healthcare together.
Roche Pharma Spain has already selected the projects that will enter the final stage of this call, focusing this year on the areas of ophthalmology and hepatocellular carcinoma.